Lilly plans to study and improve ibogaine, neuroscience leader says
Lilly’s neuroscience leader said the company wants to study and improve the psychedelic ibogaine.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.